We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Sigma-Aldrich® and AB SCIEX Sign Worldwide Distribution Agreement

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Sigma-Aldrich Corporation has signed an OEM agreement with AB SCIEX to globally distribute its mass spectrometry based tagging chemistries called SCIEX iChemistry™ Solutions for applications in basic research and applied markets.

The agreement strengthens the existing Sigma-Aldrich portfolio of reagents for mass spectrometry-based protein research, providing scientists access to the largest selection of high-quality tools for workflows to enable the study of the proteome.

Information on the portfolio can be found at www.sigma.com/mstools.

"Mass spectrometry is a rapidly growing platform driving basic proteomics research, biomarker discovery and drug development. Particularly in the Asia-Pacific region, this distribution agreement will provide the research community with easy and reliable access to AB SCIEX’s unique reagents and consumables for mass spectrometry applications as part of a total chemistry solution. Furthermore, researchers can benefit from the combined technical expertise of Sigma-Aldrich and AB SCIEX,” said Josef Zihlmann, VP Marketing, Sigma-Aldrich.

The collaboration also provides a basis for future joint development of mass spectrometry consumables.

“Sigma-Aldrich is actively expanding its portfolio of robust tools for proteomics research. In addition to establishing a complete toolset for mass spectrometry research with AB SCIEX, we are continually adding to our collection of 60,000 antibodies that enable researchers to accurately discern dynamic states of proteins in key pathways throughout the proteome,” said Zihlmann.